CVE-2026-14996
Session-management vulnerability in IBM Aspera Faspex enabling session reuse or takeover.
Is CVE-2026-14996 being exploited?
Not confirmed. CVE-2026-14996 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.22% probability of exploitation in the next 30 days.
How severe is CVE-2026-14996?
CVE-2026-14996 is rated High with a CVSS score of 8.2. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-14996?
Yes. A fix has been recorded for CVE-2026-14996. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-14996 affect?
CVE-2026-14996 affects IBM Aspera Faspex 5.0.0 - 5.0.15.4, Faspex Server. Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-14996?
Upgrade Faspex to the vendor fixed release (>=5.0.15.5) and invalidate active sessions.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Insufficient session expiration allows reuse or takeover of sessions, enabling unauthorized account access and potential data exfiltration.
Patch when possible
- affected>= 5.0.0 and <= 5.0.15.4
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.